Jeff Hackman

Jeff Hackman has extensive work experience spanning over 25 years. Jeff began their career in 1995 as Executive Director of Marketing at Aventis Pasteur. In 2001, they moved to MedImmune as Vice President of Marketing. In 2006, they joined Emergent BioSolutions as Vice President of Marketing and Sales. From 2009 to 2012, they were the Senior Vice President of Commercial Operations, President and CEO of Intercell USA at Intercell AG. From 2012 to 2015, they served as Vice President, Region Head North America Oncology at Baxalta. From 2016 to 2017, they were the Senior Vice President, Head of US Oncology and GI Franchises at Shire. In 2017, they became Interim CEO and Chief Operating Officer at Novelion Therapeutics. From 2018 to 2021, they were President, North America at EUSA Pharma. Currently, they are Chairman and CEO at Comera Life Sciences.

Jeff Hackman attended Lycoming College from 1980 to 1984, where they earned a Bachelor of Arts degree in Communications.